Pfizer, riding high on COVID-19 vaccine launch, pays CEO Bourla $21 million for 2020

Thanks to the success of its COVID-19 vaccine, the drug giant Pfizer has become a household name around the globe—and the company's eyeing $15 billion in sales from the shot this year.

For writing that 2020 success story, CEO Albert Bourla collected a pay package worth more than $21 million.